Mineralys Therapeutics, Inc.
MLYS
$25.64
-$0.45-1.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 69.20M | 53.00M | 38.60M | 31.92M | 28.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 370.79M | 171.50M | 170.60M | 184.09M | 203.07M |
| Operating Income | -370.79M | -171.50M | -170.60M | -184.09M | -203.07M |
| Income Before Tax | -349.58M | -151.78M | -154.65M | -171.36M | -190.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -349.58 | -151.78 | -154.65 | -171.36 | -190.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -349.58M | -151.78M | -154.65M | -171.36M | -190.77M |
| EBIT | -370.79M | -171.50M | -170.60M | -184.09M | -203.07M |
| EBITDA | -370.75M | -171.45M | -170.55M | -184.03M | -203.01M |
| EPS Basic | -4.24 | -2.06 | -2.38 | -2.96 | -3.57 |
| Normalized Basic EPS | -2.65 | -1.29 | -1.49 | -1.85 | -2.23 |
| EPS Diluted | -4.24 | -2.06 | -2.38 | -2.96 | -3.57 |
| Normalized Diluted EPS | -2.65 | -1.29 | -1.49 | -1.85 | -2.23 |
| Average Basic Shares Outstanding | 318.70M | 299.43M | 269.76M | 239.17M | 218.39M |
| Average Diluted Shares Outstanding | 318.70M | 299.43M | 269.76M | 239.17M | 218.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |